Hypersomatotropism in Cats: Causes, Symptoms and Treatment Options

introduction

Hypersomatotropism in cats, also known as acromegaly, is a rare but serious endocrine disorder that occurs in cats. It is caused by excessive production of the growth hormone somatotropin (STH), which leads to a range of clinical symptoms and complications. In recent years it has been shown that around 10 to 15% of cats suffering from diabetes mellitus are also affected by this disease.

Definition and causes of hypersomatotropism in cats

What is Hypersomatotropism in Cats?

characterized by excessive production of the growth hormone somatotropin (STH) This hormone, also known as growth hormone, is produced in the pituitary gland - a small gland in the brain. In normal amounts, somatotropin promotes the growth and regeneration of cells, muscles and bones. However, in cats with hypersomatotropism, this hormone is released in uncontrolled high levels, leading to a number of health problems.

Excessive production of STH causes the affected cat's tissues and organs to become enlarged. There is also a change in metabolism, which often results in resistance to insulin. This insulin resistance is a central problem as it often promotes the development or worsening of diabetes mellitus.

Causes of hypersomatotropism in cats

The main cause of hypersomatotropism in cats is an adenoma in the pituitary gland, which is a benign tumor consisting of the cells that produce somatotropin. This adenoma causes the affected cells to grow uncontrollably and continuously release large amounts of growth hormone. This process often goes undetected for a long time because the symptoms appear gradually and can initially be unspecific.

In most cases, this disease affects older cats, especially males over 8 years old. To date, no specific breed predispositions have been identified, meaning that cats of all breeds can be affected equally.

Other possible causes:

1. Hyperplasia of somatotropic cells: In rare cases, hypersomatotropism is not triggered by an adenoma, but by an increase in STH-producing cells (hyperplasia). This is a tissue change in which the cells grow unnaturally and their normal function is disrupted.
2. Hormonal dysregulation: Dysregulation of hormonal control in the pituitary gland can also lead to overproduction of somatotropin, although these cases are extremely rare.

Consequences of increased hormone production

The excess somatotropin affects the cat's body both directly and indirectly. The direct effects include increased cell proliferation, resulting in sustained tissue growth. This particularly affects bones, cartilage and soft tissue, so affected cats show noticeable physical changes such as enlargement of the paws, jaws and head.

Additionally, somatotropin has a strong insulin antagonist effect , meaning that it inhibits the action of insulin in the body. This insulin resistance leads to a significant increase in blood sugar levels and makes it difficult to control existing diabetes mellitus in cats.

The indirect effects are mediated by insulin-like growth factor 1 (IGF-1) , which is produced in the liver. IGF-1 enhances the growth-promoting effects of somatotropin and leads to further exacerbation of clinical symptoms.

In summary, hypersomatotropism in cats arises from excessive release of somatotropin, which in most cases is due to a benign tumor of the pituitary gland. This hormonal disorder leads to a variety of health problems that, if left untreated, can severely impact the affected cat's life.

Symptoms of hypersomatotropism in cats

Hypersomatotropism in cats, also known as acromegaly, leads to a variety of symptoms that often appear gradually and become very noticeable in advanced stages. Symptoms result largely from excessive production of somatotropin (STH), which acts both directly on body tissues and indirectly via insulin-like growth factor 1 (IGF-1). These two factors cause profound changes in the metabolism and growth of affected cats. In most cases, the signs of hypersomatotropism are associated with diabetes mellitus, but other growth-related symptoms also occur.

1. Diabetes mellitus and its symptoms

One of the first and most noticeable signs of hypersomatotropism is the appearance or worsening of diabetes mellitus . Due to the insulin antagonistic effect of somatotropin, affected cats develop insulin resistance. This means that insulin, which normally regulates blood sugar levels, can no longer be effective, resulting in uncontrolled high blood sugar levels.

Typical symptoms of diabetes mellitus in cats are:

• Polyuria : Affected cats urinate more frequently and in larger quantities than usual.
• Polydipsia : Increased thirst is another characteristic feature. The cat drinks an unusually large amount of water to compensate for the fluid loss caused by increased urination.
• Polyphagia : Despite an increased appetite, cats with hypersomatotropism often lose weight. They eat much more than usual, but cannot use nutrients efficiently due to impaired glucose metabolism.

2. Growth-related symptoms

Somatotropin promotes the growth of bones, cartilage and soft tissues. In the case of excessive STH levels in cats, this leads to noticeable physical changes that become more noticeable over time.

a) Enlargement of the head

One of the most noticeable physical changes in affected cats is the widening of the head . The jawbone, particularly the lower jaw (inferior prognathia), becomes larger, resulting in an overbite. This can affect the cat's eating behavior and lead to difficulty chewing.

b) Enlargement of the paws and claws

Affected cats show noticeable enlargement of their paws . The paws appear wider and stronger than normal, and the claws may become longer and thicker. This is a direct result of excess STH promoting tissue proliferation in these areas.

c) Enlargement of internal organs

In addition to the externally visible changes, hypersomatotropism also leads to an increase in the size of the internal organs . The heart and liver are particularly often affected. These organ enlargements can lead to secondary problems, particularly overload of the cardiovascular system.

3. Tooth and jaw changes

The changes in the jaw affect not only the bone itself, but also the teeth. enlargement of the interdental gaps may occur, which means that the spaces between the teeth increase. These changes can affect dental and oral health, making it easier for food particles to get stuck in the widened spaces between teeth and increasing the risk of gum disease.

4. Behavioral changes

Cats with hypersomatotropism often exhibit subtle but noticeable behavioral changes . These are primarily due to the hormonal changes and discomfort that accompany the disease. Commonly observed behavioral changes include:

• Apathy and lethargy : The cat becomes increasingly lethargic and may become withdrawn.
• Irritability : Some cats become more irritable and aggressive toward other animals or people due to the pain and stress the condition causes.

5. Neurological symptoms

Neurological symptoms occur in cats with advanced hypersomatotropism, particularly if a large pituitary adenoma is present This is because the tumor is pressing on neighboring structures in the brain. Possible neurological signs include:

• Ataxia : Difficulty coordinating movements, causing the cat to walk unsteadily or unsteadily.
• Vision problems : In some cases, the tumor can press on the optic nerve, causing vision problems or even blindness.

6. Cardiovascular symptoms

Another potentially serious symptom of hypersomatotropism is the development of hypertrophic cardiomyopathy . Chronic overproduction of somatotropin puts more strain on the heart tissue and causes the heart to enlarge, leading to thickening of the heart walls. This heart disease can lead to heart failure in the long term if not detected and treated early.

7. Coat changes

An often overlooked symptom in cats with hypersomatotropism is changes in their fur . The coat may appear coarser and less shiny, and in some cases there may be increased hair loss. These changes are often subtle, but in conjunction with the other symptoms, they may indicate the underlying disease.

The symptoms of hypersomatotropism in cats are varied and can occur gradually, so the diagnosis is often made late. Typical signs include behavioral changes, abnormal physical growth, diabetes mellitus, and neurological or cardiovascular problems. In any case of difficult-to-control diabetes mellitus or unusual growth changes, the possibility of hypersomatotropism should always be considered to enable timely diagnosis and treatment.

Diagnosis of hypersomatotropism in cats

Diagnosing hypersomatotropism in cats is a complex challenge because the symptoms of this condition often appear gradually and are initially nonspecific. Many of the affected animals suffer from diabetes mellitus, which is caused by insulin resistance. However, diagnosing diabetes alone is not enough to detect hypersomatotropism. Diagnosis requires a systematic approach to clearly detect excessive production of the growth hormone somatotropin (STH) and its effects.

1. History and clinical examination

The first step in diagnosis is a careful history and a comprehensive clinical examination . Owners often report that their cat has diabetes mellitus that is difficult to control, which can alert the veterinarian to the possibility of hypersomatotropism.

During the clinical examination, various physical signs that indicate the disease may be noticed, such as:

• Enlarged paws
• Wider head proportions
• Clear gaps between teeth
• Enlargement of the lower jaw (prognathism)

A particularly important note is the lack of response to insulin therapy in diabetes patients. Cats whose diabetes is not well controlled with high doses of insulin should be examined for hypersomatotropism.

2. Measurement of IGF-1 levels

One of the most reliable methods for diagnosing hypersomatotropism is measuring the level of IGF-1 (insulin-like growth factor 1) in the blood. IGF-1 is produced in the liver in response to somatotropin stimulation. In most cases, an increased IGF-1 level indicates excessive STH production.

Carrying out the IGF-1 measurement

There are some important points to consider when performing and interpreting IGF-1 measurement:

• Time of measurement : The measurement should only be carried out after at least 4 weeks of insulin therapy. The reason for this is that insulin is necessary for the expression of STH receptors. Without adequate insulin levels, IGF-1 levels can be falsely low, even when there is an excess of STH.
• Significant increase in IGF-1 levels : An IGF-1 level of over 1,000 ng/ml is highly suspicious for the presence of hypersomatotropism. However, the IGF-1 value alone is not enough to confirm the diagnosis.

Limitations of IGF-1 measurement

There are some factors that can affect the reliability of IGF-1 measurement. First, different laboratories may use different reference values ​​and tests, which can lead to discrepancies in results. On the other hand, the measurement can give a false negative result in cats that have not been treated with insulin for long enough.

3. Imaging procedures

To confirm the diagnosis of hypersomatotropism, the use of imaging techniques essential. This is particularly important to identify the primary cause of the disease, the pituitary adenoma, and determine its extent.

a) Computed tomography (CT)

Computed tomography is one of the preferred methods for visualizing a pituitary adenoma in cats. With the help of CT scans, the adenoma can be precisely located and the size of the tumor can be determined. This is particularly important when planning possible radiation therapy or surgical removal.

b) Magnetic resonance imaging (MRI)

Another imaging method that is commonly used is magnetic resonance imaging (MRI). It provides high-resolution images of the brain and enables a detailed representation of the pituitary gland. MRI is particularly useful for assessing the size and growth pattern of the adenoma, particularly if neurological symptoms are suspected.

When are imaging procedures necessary?

Imaging tests should be performed on all cats with elevated IGF-1 levels to confirm the diagnosis of hypersomatotropism. Even cats with unclear neurological symptoms require imaging to identify a pituitary adenoma or other brain changes.

4. Examination of insulin requirements

Another indication of the presence of hypersomatotropism can be the affected cat's increased insulin requirement . Many cats require very high doses of insulin to control their diabetes mellitus. Typical insulin doses in affected cats are often far higher than those used for normal diabetes. This is due to the insulin antagonist effect of somatotropin, which makes the body less sensitive to the insulin administered.

5. Additional laboratory diagnostics

In addition to determining the IGF-1 level, other laboratory tests can also provide evidence of the presence of hypersomatotropism. These include:

• Blood sugar levels : Blood sugar levels in affected cats are often highly elevated and difficult to control.
• Fructosamine value : An elevated fructosamine value indicates chronically poor blood sugar control, which can be a further indication of insulin resistance and possible hypersomatotropism.

6. Examination of secondary complications

results in secondary diseases such as hypertrophic cardiomyopathy This can be done through ultrasound scans or x-rays to determine the extent of organ involvement.

Diagnosis of hypersomatotropism in cats requires a thorough and systematic approach that combines clinical symptoms, IGF-1 measurement results, and imaging findings. Suspicion of this endocrine disorder should be considered early, especially in cats with difficult-to-control diabetes mellitus. Early diagnosis is crucial in order to plan appropriate treatment options and improve the well-being of the affected cat.

Treatment options for hypersomatotropism in cats

Treating hypersomatotropism in cats is a challenging task as the condition involves both the excessive production of growth hormone (somatotropin, STH) and the health problems it causes, such as diabetes mellitus. Treatment options aim to reduce hormone excess while controlling the associated metabolic complications. The various therapeutic approaches are explained in detail below.

1. Surgical therapy – hypophysectomy

Hypophysectomy the surgical removal of the pituitary gland, is one of the most effective methods for treating hypersomatotropism because it directly removes the adenoma that is responsible for the excessive production of somatotropin. However, this form of therapy is only carried out in specialized clinics because it is a very demanding procedure.

Benefits of Hypophysectomy:

• Direct removal of the tumor : The procedure aims to eliminate the cause of the excess hormone, which can lead to normalization of hormone levels.
• Potential cure for diabetes mellitus : Since STH excess causes insulin resistance, successful hypophysectomy can lead to remission of diabetes, which can reduce or even eliminate the need for insulin therapy.

Risks and challenges:

• High technical requirements : The operation requires experienced surgeons and special equipment, which limits the availability of this procedure to a few veterinary clinics.
• Risks from proximity to the brain : Because the pituitary gland is located in the brain, there is some risk of neurological damage or other complications.
• Hormonal follow-up care : After removal of the pituitary gland, cats may require life-long hormone replacement therapy (such as corticosteroids or thyroid hormones) to compensate for the pituitary gland's lack of hormonal function.

2. radiotherapy

Radiation therapy is currently the most commonly used treatment method for cats with hypersomatotropism. It aims to shrink or destroy the pituitary adenoma, thereby reducing the production of somatotropin. This treatment may be an alternative to surgical removal, especially when surgery is not possible.

Benefits of Radiation Therapy:

• Non-invasive : Unlike surgery, radiation therapy is non-invasive, making it particularly suitable for cats at increased risk of surgery.
• Successful reduction of tumor growth : Radiation therapy can stop or significantly slow the growth of the tumor, resulting in an improvement in clinical symptoms.
• Diabetes remission possible : In many cases, after successful radiation therapy, hormone levels return to normal and diabetes mellitus can improve significantly or disappear completely.

Challenges of radiotherapy:

• Multiple Sessions Required : Cats often require multiple sessions of radiation therapy over a period of time, which lengthens the treatment process.
• Late effect : The effects of radiation therapy are not immediate and it may take several months for hormone levels and clinical symptoms to stabilize.
• Side effects : While most cats tolerate radiation therapy well, some cases may experience side effects such as skin irritation or inflammation.

3. Medical therapy

Drug treatment for hypersomatotropism in cats currently has limited effectiveness. In human medicine, somatostatin analogues such as octreotide are used to inhibit the production of somatotropin. However, this therapy has only limited success in cats.

Somatostatin analogues:

• Octreotide : This drug inhibits the release of somatotropin from the pituitary gland by binding to specific receptors. However, in cats, studies have shown that in most cases the response to octreotide is not sufficient to cause significant improvement in symptoms.
• Long-term effects : In rare cases, the administration of somatostatin analogues in combination with other therapies can provide some relief of symptoms. However, this form of therapy is rarely used in practice due to its lack of effectiveness in cats.

Other drug approaches:

• Pegvisomant : Another drug that could theoretically be used to treat hypersomatotropism is pegvisomant. This drug blocks the effects of somatotropin on target organs. Here too, however, there are so far no convincing results in veterinary medicine.

4. Diabetes therapy

The treatment of diabetes mellitus , which is caused by hypersomatotropism, is a central part of therapy. Due to the insulin antagonistic effects of somatotropin, it is often difficult to control diabetes in affected cats. Intensive insulin therapy is therefore necessary.

Insulin therapy for hypersomatotropism:

• High insulin doses : Cats with hypersomatotropism usually require significantly higher insulin doses than cats with “normal” diabetes mellitus. This is because somatotropin strongly inhibits the effects of insulin.
• Regular blood sugar checks : Close monitoring of blood sugar levels is crucial to optimally adjust the insulin dose. In some cases, daily adjustments may be necessary to achieve the best possible control of diabetes.
• Possible remission : If the underlying cause of hypersomatotropism is successfully treated (e.g., by radiation or surgical therapy), the diabetes may go into remission in some cases, so insulin therapy may be reduced or even discontinued.

5. Aftercare and quality of life

Long-term monitoring plays a critical role in the management of cats with hypersomatotropism. Even after successful therapy, regular check-ups are necessary to monitor the recurrence of symptoms or the progression of the disease.

Regular aftercare:

• Monitoring hormone levels : Even after successful radiation therapy or hypophysectomy, somatotropin and IGF-1 levels should be checked regularly to ensure that hormone levels remain stable.
• Diabetes management : Insulin therapy must be continued in cats whose diabetes does not go into remission. Regular checks and adjustments of the insulin dose are essential.
• Monitor for secondary complications : Because hypersomatotropism often leads to secondary complications such as heart problems (e.g. hypertrophic cardiomyopathy), these should also be monitored and treated if necessary.

Improving quality of life:

• Adapted diet : A special diet that keeps blood sugar levels stable and avoids obesity can help improve the cat's quality of life.
• Behavior monitoring : Owners should closely monitor their cat's behavior in order to respond in a timely manner to any changes that could indicate a worsening condition.

Conclusion

Treatment of hypersomatotropism in cats requires a comprehensive and multidisciplinary approach aimed at both controlling the tumor and treating the symptoms caused by hormone overproduction. Surgical interventions, radiation therapy and intensive diabetes therapy are the most important treatment methods, while drug therapy usually only plays a minor role. Early diagnosis and targeted therapy can significantly improve the quality of life of affected cats and in some cases even lead to complete remission.

FAQ: Hypersomatotropism in cats

Summary of hypersomatotropism in cats

Hypersomatotropism in cats is a rare but serious endocrine disorder caused by excessive production of the growth hormone somatotropin (STH). This condition usually occurs in older cats, especially males. In most cases, hypersomatotropism in cats arises from a benign adenoma of the pituitary gland, which is responsible for the excessive secretion of somatotropin.

Insulin resistance caused by hypersomatotropism in cats often leads to poorly controlled diabetes mellitus. Typical symptoms of hypersomatotropism in cats include increased drinking and urination, increased appetite and simultaneous weight loss. In addition, hypersomatotropism in cats manifests itself in physical changes such as enlargement of the head, especially the jaw, as well as enlarged paws and interdental spaces.

Diagnosis of hypersomatotropism in cats is made by measuring IGF-1 levels in the blood, as this hormone marker is highly elevated in affected animals. To confirm the diagnosis and demonstrate the presence of a tumor in the pituitary gland, imaging tests such as CT or MRI are necessary. Hypersomatotropism in cats requires a specialized and thorough examination to initiate proper therapy.

There are many treatment options for hypersomatotropism in cats. Surgical removal of the pituitary adenoma, the so-called hypophysectomy, is considered one of the most effective methods, but is only carried out in specialized clinics. Alternatively, radiation therapy is often used to shrink the adenoma and stop excessive production of somatotropin. Successful treatment of hypersomatotropism in cats can lead to remission of diabetes mellitus in some cases.

In addition to treating the tumor, diabetes mellitus, which is caused by hypersomatotropism in cats, also needs to be treated intensively. Because hypersomatotropism in cats leads to increased insulin resistance, affected animals often require high doses of insulin to stabilize their blood sugar levels. Without proper treatment, hypersomatotropism in cats can lead to serious complications, including organ enlargement and heart problems.

Early diagnosis of hypersomatotropism in cats is crucial to improve the quality of life of affected animals. Cats with hypersomatotropism require close veterinary monitoring to control the progression of the disease and prevent complications.

Overall, hypersomatotropism in cats is a challenging disorder that affects both metabolic processes and growth. However, with proper therapy and a targeted treatment plan, hypersomatotropism in cats can be successfully managed.

Early detection of hypersomatotropism in cats makes it possible to initiate therapeutic measures in a timely manner and slow down the progression of the disease. Hypersomatotropism in cats be considered as a possible cause, particularly in cats with difficult-to-control diabetes Veterinarians confronted with diabetes patients should therefore always keep in mind hypersomatotropism in cats

In addition to surgical removal of the tumor and radiation therapy, long-term management of diabetes is a crucial part of the treatment of hypersomatotropism in cats . The combination of high insulin dosage and an adjusted diet can help control the metabolic hypersomatotropism in cats

The prognosis depends heavily on how early hypersomatotropism in cats is diagnosed and what treatment options are available. While some cats respond well to therapy and achieve diabetes remission, there are also cases where hypersomatotropism in cats progresses and leads to further complications, such as hypertrophic cardiomyopathy or other organ enlargements.

Research into hypersomatotropism in cats is constantly progressing, and new treatments may enable even better control of the disease in the future. Pet owners whose cats are affected by feline hypersomatotropism should coordinate closely with their veterinarian to ensure the best possible care and follow-up care.

In summary, hypersomatotropism in cats is a serious but treatable condition. With a combination of targeted diagnosis, advanced therapies and long-term care, hypersomatotropism in cats be successfully managed so that affected animals can lead full and largely normal lives. Early intervention and ongoing monitoring are crucial to achieve the best results for the cat's health and well-being.

Further information including: https://www.cliniciansbrief.com/article/prednisolone-development-diabetes-mellitus-cats